APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prognostic and Health Management（PHM）

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prognostic and Health Management（PHM） Market Analysis and Forecast 2026-2032

22 January 2026201 pages

Choose your research edition.

Industry ResearchPrognostic and Health Management（PHM） Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prognostic and Health Management（PHM） Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prognostic and Health Management（PHM） Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prognostic and Health Management（PHM） Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Prognostic and Health Management（PHM） Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Prognostic and Health Management（PHM） market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Prognostic and Health Management（PHM） is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prognostic and Health Management（PHM） is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prognostic and Health Management（PHM） is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prognostic and Health Management（PHM） is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Prognostic and Health Management（PHM） include SKF, Baker Hughes, NSK Global, Emerson, Augury, GE, Meggitt, Uptake and Schaeffler, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Prognostic and Health Management（PHM）, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prognostic and Health Management（PHM）, also provides the revenue of main regions and countries. Of the upcoming market potential for Prognostic and Health Management（PHM）, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prognostic and Health Management（PHM） revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prognostic and Health Management（PHM） market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Prognostic and Health Management（PHM） revenue, projected growth trends, production technology, application and end-user industry.

Prognostic and Health Management（PHM） Segment by Company

SKF

Baker Hughes

NSK Global

Emerson

Augury

GE

Meggitt

Uptake

Schaeffler

IBM

Schneider Electric

ABB

Siemens

Ronds Science & Technology

DongHua Testing Technology

Beijing Bohua Xinzhi Technology

Wuhan Zhongyun Kangchong Technology

ChinaEnergy CyberWing Technology

Beijing Weiruida Control System

Prognostic and Health Management（PHM） Segment by Type

On-Premises

Cloud Based

Prognostic and Health Management（PHM） Segment by Application

Petrochemical

Power

Iron and Steel Metallurgy

Cement and Building Materials

Aerospace and Defense

Rail Transit

Intelligent Manufacturing

Others

Prognostic and Health Management（PHM） Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prognostic and Health Management（PHM） market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prognostic and Health Management（PHM） and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prognostic and Health Management（PHM）.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Prognostic and Health Management（PHM） in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Prognostic and Health Management（PHM） company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prognostic and Health Management（PHM） revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prognostic and Health Management（PHM） Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-Premises Major Player Table 3. Cloud Based Major Player Table 4. Global Prognostic and Health Management（PHM） Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Petrochemical Major Player Table 6. Power Major Player Table 7. Iron and Steel Metallurgy Major Player Table 8. Cement and Building Materials Major Player Table 9. Aerospace and Defense Major Player Table 10. Rail Transit Major Player Table 11. Intelligent Manufacturing Major Player Table 12. Others Major Player Table 13. Prognostic and Health Management（PHM） Industry Trends Table 14. Prognostic and Health Management（PHM） Industry Drivers Table 15. Prognostic and Health Management（PHM） Industry Opportunities and Challenges Table 16. Prognostic and Health Management（PHM） Industry Restraints Table 17. Global Prognostic and Health Management（PHM） Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Prognostic and Health Management（PHM） Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Prognostic and Health Management（PHM） Market Share by Region (2021-2026) Table 20. Global Prognostic and Health Management（PHM） Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Prognostic and Health Management（PHM） Market Share by Region (2027-2032) Table 22. Global Prognostic and Health Management（PHM） Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Prognostic and Health Management（PHM） Revenue Market Share by Players (2021-2026) Table 24. Global Prognostic and Health Management（PHM） Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Prognostic and Health Management（PHM） Key Players Headquarters & Area Served Table 26. Global Prognostic and Health Management（PHM） Players, Product Type & Application Table 27. Global Prognostic and Health Management（PHM） Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Prognostic and Health Management（PHM） by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Prognostic and Health Management（PHM） Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Prognostic and Health Management（PHM） Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Prognostic and Health Management（PHM） Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Prognostic and Health Management（PHM） Revenue Market Share by Type (2021-2026) Table 34. Global Prognostic and Health Management（PHM） Revenue Market Share by Type (2027-2032) Table 35. Global Prognostic and Health Management（PHM） Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prognostic and Health Management（PHM） Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Prognostic and Health Management（PHM） Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Prognostic and Health Management（PHM） Revenue Market Share by Application (2021-2026) Table 39. Global Prognostic and Health Management（PHM） Revenue Market Share by Application (2027-2032) Table 40. SKF Company Information Table 41. SKF Business Overview Table 42. SKF Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. SKF Prognostic and Health Management（PHM） Product Portfolio Table 44. SKF Recent Development Table 45. Baker Hughes Company Information Table 46. Baker Hughes Business Overview Table 47. Baker Hughes Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Baker Hughes Prognostic and Health Management（PHM） Product Portfolio Table 49. Baker Hughes Recent Development Table 50. NSK Global Company Information Table 51. NSK Global Business Overview Table 52. NSK Global Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. NSK Global Prognostic and Health Management（PHM） Product Portfolio Table 54. NSK Global Recent Development Table 55. Emerson Company Information Table 56. Emerson Business Overview Table 57. Emerson Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Emerson Prognostic and Health Management（PHM） Product Portfolio Table 59. Emerson Recent Development Table 60. Augury Company Information Table 61. Augury Business Overview Table 62. Augury Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Augury Prognostic and Health Management（PHM） Product Portfolio Table 64. Augury Recent Development Table 65. GE Company Information Table 66. GE Business Overview Table 67. GE Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GE Prognostic and Health Management（PHM） Product Portfolio Table 69. GE Recent Development Table 70. Meggitt Company Information Table 71. Meggitt Business Overview Table 72. Meggitt Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Meggitt Prognostic and Health Management（PHM） Product Portfolio Table 74. Meggitt Recent Development Table 75. Uptake Company Information Table 76. Uptake Business Overview Table 77. Uptake Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Uptake Prognostic and Health Management（PHM） Product Portfolio Table 79. Uptake Recent Development Table 80. Schaeffler Company Information Table 81. Schaeffler Business Overview Table 82. Schaeffler Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Schaeffler Prognostic and Health Management（PHM） Product Portfolio Table 84. Schaeffler Recent Development Table 85. IBM Company Information Table 86. IBM Business Overview Table 87. IBM Prognostic and Health Management（PHM） Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. IBM Prognostic and Health Management（PHM） Product Portfolio Table 89. IBM Recent Development Table 90. Schneider Electric Company Information Table 91. Schneider Electric Business Overview Table 92. Schneider Electric Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Schneider Electric Prognostic and Health Management（PHM） Product Portfolio Table 94. Schneider Electric Recent Development Table 95. ABB Company Information Table 96. ABB Business Overview Table 97. ABB Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. ABB Prognostic and Health Management（PHM） Product Portfolio Table 99. ABB Recent Development Table 100. Siemens Company Information Table 101. Siemens Business Overview Table 102. Siemens Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Siemens Prognostic and Health Management（PHM） Product Portfolio Table 104. Siemens Recent Development Table 105. Ronds Science & Technology Company Information Table 106. Ronds Science & Technology Business Overview Table 107. Ronds Science & Technology Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Ronds Science & Technology Prognostic and Health Management（PHM） Product Portfolio Table 109. Ronds Science & Technology Recent Development Table 110. DongHua Testing Technology Company Information Table 111. DongHua Testing Technology Business Overview Table 112. DongHua Testing Technology Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. DongHua Testing Technology Prognostic and Health Management（PHM） Product Portfolio Table 114. DongHua Testing Technology Recent Development Table 115. Beijing Bohua Xinzhi Technology Company Information Table 116. Beijing Bohua Xinzhi Technology Business Overview Table 117. Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Product Portfolio Table 119. Beijing Bohua Xinzhi Technology Recent Development Table 120. Wuhan Zhongyun Kangchong Technology Company Information Table 121. Wuhan Zhongyun Kangchong Technology Business Overview Table 122. Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Product Portfolio Table 124. Wuhan Zhongyun Kangchong Technology Recent Development Table 125. ChinaEnergy CyberWing Technology Company Information Table 126. ChinaEnergy CyberWing Technology Business Overview Table 127. ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Product Portfolio Table 129. ChinaEnergy CyberWing Technology Recent Development Table 130. Beijing Weiruida Control System Company Information Table 131. Beijing Weiruida Control System Business Overview Table 132. Beijing Weiruida Control System Prognostic and Health Management（PHM） Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Beijing Weiruida Control System Prognostic and Health Management（PHM） Product Portfolio Table 134. Beijing Weiruida Control System Recent Development Table 135. North America Prognostic and Health Management（PHM） Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Prognostic and Health Management（PHM） Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Prognostic and Health Management（PHM） Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Prognostic and Health Management（PHM） Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Prognostic and Health Management（PHM） Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Prognostic and Health Management（PHM） Revenue by Country (US$ Million) & (2027-2032) Table 142. Europe Prognostic and Health Management（PHM） Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Prognostic and Health Management（PHM） Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Prognostic and Health Management（PHM） Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Prognostic and Health Management（PHM） Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Prognostic and Health Management（PHM） Revenue by Country (2021-2026) & (US$ Million) Table 148. Europe Prognostic and Health Management（PHM） Revenue by Country (US$ Million) & (2027-2032) Table 149. China Prognostic and Health Management（PHM） Revenue by Type (2021-2026) & (US$ Million) Table 150. China Prognostic and Health Management（PHM） Revenue by Type (2027-2032) & (US$ Million) Table 151. China Prognostic and Health Management（PHM） Revenue by Application (2021-2026) & (US$ Million) Table 152. China Prognostic and Health Management（PHM） Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Prognostic and Health Management（PHM） Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Prognostic and Health Management（PHM） Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Prognostic and Health Management（PHM） Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Prognostic and Health Management（PHM） Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Prognostic and Health Management（PHM） Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Prognostic and Health Management（PHM） Revenue by Region (US$ Million) & (2021-2026) Table 159. Asia Prognostic and Health Management（PHM） Revenue by Region (US$ Million) & (2027-2032) Table 160. SAMEA Prognostic and Health Management（PHM） Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Prognostic and Health Management（PHM） Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Prognostic and Health Management（PHM） Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Prognostic and Health Management（PHM） Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Prognostic and Health Management（PHM） Revenue by Country (2021-2026) & (US$ Million) Table 166. SAMEA Prognostic and Health Management（PHM） Revenue by Country (US$ Million) & (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Prognostic and Health Management（PHM） Image Figure 2. Global Prognostic and Health Management（PHM） Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prognostic and Health Management（PHM） Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-Premises Image Figure 5. Cloud Based Image Figure 6. Global Prognostic and Health Management（PHM） Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Prognostic and Health Management（PHM） Market Size Share 2021 VS 2025 VS 2032 Figure 8. Petrochemical Image Figure 9. Power Image Figure 10. Iron and Steel Metallurgy Image Figure 11. Cement and Building Materials Image Figure 12. Aerospace and Defense Image Figure 13. Rail Transit Image Figure 14. Intelligent Manufacturing Image Figure 15. Others Image Figure 16. Global Prognostic and Health Management（PHM） Market Size (US$ Million) & (2021-2032) Figure 17. Global Prognostic and Health Management（PHM） Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Prognostic and Health Management（PHM） Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Prognostic and Health Management（PHM） Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Prognostic and Health Management（PHM） Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Prognostic and Health Management（PHM） Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Prognostic and Health Management（PHM） Revenue Market Share by Type (2021-2032) Figure 24. Global Prognostic and Health Management（PHM） Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Prognostic and Health Management（PHM） Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Prognostic and Health Management（PHM） Revenue Market Share by Application (2021-2032) Figure 27. North America Prognostic and Health Management（PHM） Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032) Figure 29. North America Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032) Figure 30. North America Prognostic and Health Management（PHM） Revenue Share by Country (2021-2032) Figure 31. United States Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Prognostic and Health Management（PHM） Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032) Figure 36. Europe Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032) Figure 37. Europe Prognostic and Health Management（PHM） Revenue Share by Country (2021-2032) Figure 38. Germany Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Prognostic and Health Management（PHM） Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032) Figure 48. China Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032) Figure 49. Asia Prognostic and Health Management（PHM） Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032) Figure 51. Asia Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032) Figure 52. Asia Prognostic and Health Management（PHM） Revenue Share by Region (2021-2032) Figure 53. Japan Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Prognostic and Health Management（PHM） Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032) Figure 61. SAMEA Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032) Figure 62. SAMEA Prognostic and Health Management（PHM） Revenue Share by Country (2021-2032) Figure 63. Brazil Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Prognostic and Health Management（PHM） Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premises
  • Cloud Based
Applications
  • Petrochemical
  • Power
  • Iron and Steel Metallurgy
  • Cement and Building Materials
  • Aerospace and Defense
  • Rail Transit
  • Intelligent Manufacturing
  • Others
Companies covered
  • SKF
  • Baker Hughes
  • NSK Global
  • Emerson
  • Augury
  • GE
  • Meggitt
  • Uptake
  • Schaeffler
  • IBM
  • Schneider Electric
  • ABB
  • Siemens
  • Ronds Science & Technology
  • DongHua Testing Technology
  • Beijing Bohua Xinzhi Technology
  • Wuhan Zhongyun Kangchong Technology
  • ChinaEnergy CyberWing Technology
  • Beijing Weiruida Control System

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prognostic and Health Management（PHM） Market by Type
  3. 1.2.1 Global Prognostic and Health Management（PHM） Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-Premises
  5. 1.2.3 Cloud Based
  6. 1.3 Prognostic and Health Management（PHM） Market by Application
  7. 1.3.1 Global Prognostic and Health Management（PHM） Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Petrochemical
  9. 1.3.3 Power
  10. 1.3.4 Iron and Steel Metallurgy
  11. 1.3.5 Cement and Building Materials
  12. 1.3.6 Aerospace and Defense
  13. 1.3.7 Rail Transit
  14. 1.3.8 Intelligent Manufacturing
  15. 1.3.9 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Prognostic and Health Management（PHM） Market Dynamics
  1. 2.1 Prognostic and Health Management（PHM） Industry Trends
  2. 2.2 Prognostic and Health Management（PHM） Industry Drivers
  3. 2.3 Prognostic and Health Management（PHM） Industry Opportunities and Challenges
  4. 2.4 Prognostic and Health Management（PHM） Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Prognostic and Health Management（PHM） Market Perspective (2021-2032)
  2. 3.2 Global Prognostic and Health Management（PHM） Growth Trends by Region
  3. 3.2.1 Global Prognostic and Health Management（PHM） Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prognostic and Health Management（PHM） Market Size by Region (2021-2026)
  5. 3.2.3 Global Prognostic and Health Management（PHM） Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Prognostic and Health Management（PHM） Revenue by Players
  2. 4.1.1 Global Prognostic and Health Management（PHM） Revenue by Players (2021-2026)
  3. 4.1.2 Global Prognostic and Health Management（PHM） Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Prognostic and Health Management（PHM） Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prognostic and Health Management（PHM） Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Prognostic and Health Management（PHM） Key Players Headquarters & Area Served
  7. 4.4 Global Prognostic and Health Management（PHM） Players, Product Type & Application
  8. 4.5 Global Prognostic and Health Management（PHM） Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Prognostic and Health Management（PHM） Market CR5 and HHI
  11. 4.6.3 2025 Prognostic and Health Management（PHM） Tier 1, Tier 2, and Tier 3
5 Prognostic and Health Management（PHM） Market Size by Type
  1. 5.1 Global Prognostic and Health Management（PHM） Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Prognostic and Health Management（PHM） Revenue by Type (2021-2032)
  3. 5.3 Global Prognostic and Health Management（PHM） Revenue Market Share by Type (2021-2032)
6 Prognostic and Health Management（PHM） Market Size by Application
  1. 6.1 Global Prognostic and Health Management（PHM） Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Prognostic and Health Management（PHM） Revenue by Application (2021-2032)
  3. 6.3 Global Prognostic and Health Management（PHM） Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SKF
  2. 7.1.1 SKF Company Information
  3. 7.1.2 SKF Business Overview
  4. 7.1.3 SKF Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SKF Prognostic and Health Management（PHM） Product Portfolio
  6. 7.1.5 SKF Recent Developments
  7. 7.2 Baker Hughes
  8. 7.2.1 Baker Hughes Company Information
  9. 7.2.2 Baker Hughes Business Overview
  10. 7.2.3 Baker Hughes Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Baker Hughes Prognostic and Health Management（PHM） Product Portfolio
  12. 7.2.5 Baker Hughes Recent Developments
  13. 7.3 NSK Global
  14. 7.3.1 NSK Global Company Information
  15. 7.3.2 NSK Global Business Overview
  16. 7.3.3 NSK Global Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  17. 7.3.4 NSK Global Prognostic and Health Management（PHM） Product Portfolio
  18. 7.3.5 NSK Global Recent Developments
  19. 7.4 Emerson
  20. 7.4.1 Emerson Company Information
  21. 7.4.2 Emerson Business Overview
  22. 7.4.3 Emerson Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Emerson Prognostic and Health Management（PHM） Product Portfolio
  24. 7.4.5 Emerson Recent Developments
  25. 7.5 Augury
  26. 7.5.1 Augury Company Information
  27. 7.5.2 Augury Business Overview
  28. 7.5.3 Augury Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Augury Prognostic and Health Management（PHM） Product Portfolio
  30. 7.5.5 Augury Recent Developments
  31. 7.6 GE
  32. 7.6.1 GE Company Information
  33. 7.6.2 GE Business Overview
  34. 7.6.3 GE Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GE Prognostic and Health Management（PHM） Product Portfolio
  36. 7.6.5 GE Recent Developments
  37. 7.7 Meggitt
  38. 7.7.1 Meggitt Company Information
  39. 7.7.2 Meggitt Business Overview
  40. 7.7.3 Meggitt Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Meggitt Prognostic and Health Management（PHM） Product Portfolio
  42. 7.7.5 Meggitt Recent Developments
  43. 7.8 Uptake
  44. 7.8.1 Uptake Company Information
  45. 7.8.2 Uptake Business Overview
  46. 7.8.3 Uptake Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Uptake Prognostic and Health Management（PHM） Product Portfolio
  48. 7.8.5 Uptake Recent Developments
  49. 7.9 Schaeffler
  50. 7.9.1 Schaeffler Company Information
  51. 7.9.2 Schaeffler Business Overview
  52. 7.9.3 Schaeffler Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Schaeffler Prognostic and Health Management（PHM） Product Portfolio
  54. 7.9.5 Schaeffler Recent Developments
  55. 7.10 IBM
  56. 7.10.1 IBM Company Information
  57. 7.10.2 IBM Business Overview
  58. 7.10.3 IBM Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IBM Prognostic and Health Management（PHM） Product Portfolio
  60. 7.10.5 IBM Recent Developments
  61. 7.11 Schneider Electric
  62. 7.11.1 Schneider Electric Company Information
  63. 7.11.2 Schneider Electric Business Overview
  64. 7.11.3 Schneider Electric Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Schneider Electric Prognostic and Health Management（PHM） Product Portfolio
  66. 7.11.5 Schneider Electric Recent Developments
  67. 7.12 ABB
  68. 7.12.1 ABB Company Information
  69. 7.12.2 ABB Business Overview
  70. 7.12.3 ABB Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ABB Prognostic and Health Management（PHM） Product Portfolio
  72. 7.12.5 ABB Recent Developments
  73. 7.13 Siemens
  74. 7.13.1 Siemens Company Information
  75. 7.13.2 Siemens Business Overview
  76. 7.13.3 Siemens Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Siemens Prognostic and Health Management（PHM） Product Portfolio
  78. 7.13.5 Siemens Recent Developments
  79. 7.14 Ronds Science & Technology
  80. 7.14.1 Ronds Science & Technology Company Information
  81. 7.14.2 Ronds Science & Technology Business Overview
  82. 7.14.3 Ronds Science & Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Ronds Science & Technology Prognostic and Health Management（PHM） Product Portfolio
  84. 7.14.5 Ronds Science & Technology Recent Developments
  85. 7.15 DongHua Testing Technology
  86. 7.15.1 DongHua Testing Technology Company Information
  87. 7.15.2 DongHua Testing Technology Business Overview
  88. 7.15.3 DongHua Testing Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  89. 7.15.4 DongHua Testing Technology Prognostic and Health Management（PHM） Product Portfolio
  90. 7.15.5 DongHua Testing Technology Recent Developments
  91. 7.16 Beijing Bohua Xinzhi Technology
  92. 7.16.1 Beijing Bohua Xinzhi Technology Company Information
  93. 7.16.2 Beijing Bohua Xinzhi Technology Business Overview
  94. 7.16.3 Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Product Portfolio
  96. 7.16.5 Beijing Bohua Xinzhi Technology Recent Developments
  97. 7.17 Wuhan Zhongyun Kangchong Technology
  98. 7.17.1 Wuhan Zhongyun Kangchong Technology Company Information
  99. 7.17.2 Wuhan Zhongyun Kangchong Technology Business Overview
  100. 7.17.3 Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Product Portfolio
  102. 7.17.5 Wuhan Zhongyun Kangchong Technology Recent Developments
  103. 7.18 ChinaEnergy CyberWing Technology
  104. 7.18.1 ChinaEnergy CyberWing Technology Company Information
  105. 7.18.2 ChinaEnergy CyberWing Technology Business Overview
  106. 7.18.3 ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  107. 7.18.4 ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Product Portfolio
  108. 7.18.5 ChinaEnergy CyberWing Technology Recent Developments
  109. 7.19 Beijing Weiruida Control System
  110. 7.19.1 Beijing Weiruida Control System Company Information
  111. 7.19.2 Beijing Weiruida Control System Business Overview
  112. 7.19.3 Beijing Weiruida Control System Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Beijing Weiruida Control System Prognostic and Health Management（PHM） Product Portfolio
  114. 7.19.5 Beijing Weiruida Control System Recent Developments
8 North America
  1. 8.1 North America Prognostic and Health Management（PHM） Revenue (2021-2032)
  2. 8.2 North America Prognostic and Health Management（PHM） Revenue by Type (2021-2032)
  3. 8.2.1 North America Prognostic and Health Management（PHM） Revenue by Type (2021-2026)
  4. 8.2.2 North America Prognostic and Health Management（PHM） Revenue by Type (2027-2032)
  5. 8.3 North America Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032)
  6. 8.4 North America Prognostic and Health Management（PHM） Revenue by Application (2021-2032)
  7. 8.4.1 North America Prognostic and Health Management（PHM） Revenue by Application (2021-2026)
  8. 8.4.2 North America Prognostic and Health Management（PHM） Revenue by Application (2027-2032)
  9. 8.5 North America Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032)
  10. 8.6 North America Prognostic and Health Management（PHM） Revenue by Country
  11. 8.6.1 North America Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Prognostic and Health Management（PHM） Revenue by Country (2021-2026)
  13. 8.6.3 North America Prognostic and Health Management（PHM） Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Prognostic and Health Management（PHM） Revenue (2021-2032)
  2. 9.2 Europe Prognostic and Health Management（PHM） Revenue by Type (2021-2032)
  3. 9.2.1 Europe Prognostic and Health Management（PHM） Revenue by Type (2021-2026)
  4. 9.2.2 Europe Prognostic and Health Management（PHM） Revenue by Type (2027-2032)
  5. 9.3 Europe Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032)
  6. 9.4 Europe Prognostic and Health Management（PHM） Revenue by Application (2021-2032)
  7. 9.4.1 Europe Prognostic and Health Management（PHM） Revenue by Application (2021-2026)
  8. 9.4.2 Europe Prognostic and Health Management（PHM） Revenue by Application (2027-2032)
  9. 9.5 Europe Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032)
  10. 9.6 Europe Prognostic and Health Management（PHM） Revenue by Country
  11. 9.6.1 Europe Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Prognostic and Health Management（PHM） Revenue by Country (2021-2026)
  13. 9.6.3 Europe Prognostic and Health Management（PHM） Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Prognostic and Health Management（PHM） Revenue (2021-2032)
  2. 10.2 China Prognostic and Health Management（PHM） Revenue by Type (2021-2032)
  3. 10.2.1 China Prognostic and Health Management（PHM） Revenue by Type (2021-2026)
  4. 10.2.2 China Prognostic and Health Management（PHM） Revenue by Type (2027-2032)
  5. 10.3 China Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032)
  6. 10.4 China Prognostic and Health Management（PHM） Revenue by Application (2021-2032)
  7. 10.4.1 China Prognostic and Health Management（PHM） Revenue by Application (2021-2026)
  8. 10.4.2 China Prognostic and Health Management（PHM） Revenue by Application (2027-2032)
  9. 10.5 China Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prognostic and Health Management（PHM） Revenue (2021-2032)
  2. 11.2 Asia Prognostic and Health Management（PHM） Revenue by Type (2021-2032)
  3. 11.2.1 Asia Prognostic and Health Management（PHM） Revenue by Type (2021-2026)
  4. 11.2.2 Asia Prognostic and Health Management（PHM） Revenue by Type (2027-2032)
  5. 11.3 Asia Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032)
  6. 11.4 Asia Prognostic and Health Management（PHM） Revenue by Application (2021-2032)
  7. 11.4.1 Asia Prognostic and Health Management（PHM） Revenue by Application (2021-2026)
  8. 11.4.2 Asia Prognostic and Health Management（PHM） Revenue by Application (2027-2032)
  9. 11.5 Asia Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032)
  10. 11.6 Asia Prognostic and Health Management（PHM） Revenue by Country
  11. 11.6.1 Asia Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Prognostic and Health Management（PHM） Revenue by Country (2021-2026)
  13. 11.6.3 Asia Prognostic and Health Management（PHM） Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prognostic and Health Management（PHM） Revenue (2021-2032)
  2. 12.2 SAMEA Prognostic and Health Management（PHM） Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Prognostic and Health Management（PHM） Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Prognostic and Health Management（PHM） Revenue by Type (2027-2032)
  5. 12.3 SAMEA Prognostic and Health Management（PHM） Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Prognostic and Health Management（PHM） Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Prognostic and Health Management（PHM） Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Prognostic and Health Management（PHM） Revenue by Application (2027-2032)
  9. 12.5 SAMEA Prognostic and Health Management（PHM） Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Prognostic and Health Management（PHM） Revenue by Country
  11. 12.6.1 SAMEA Prognostic and Health Management（PHM） Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Prognostic and Health Management（PHM） Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Prognostic and Health Management（PHM） Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst